c2n developed amyloid score
ConceptMentioned in 1 video
A biomarker score that uses APOE variant, amyloid beta ratio (40/42), and age to predict AD pathology probability.
A biomarker score that uses APOE variant, amyloid beta ratio (40/42), and age to predict AD pathology probability.